SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-19-007013
Filing Date
2019-03-15
Accepted
2019-03-15 20:03:23
Documents
1
Period of Report
2019-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 3850
  Complete submission text file 0001567619-19-007013.txt   5589
Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1

Mailing Address BUILDING 227, TETRICUS SCIENCE PARK PORTON DOWN, SALISBURY WILTSHIRE X0 SP4 0JQ
Business Address
Crockett Thomas Andrew (Reporting) CIK: 0001690920 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 19686501